2BB score and signals
Insight Molecular Diagnostics Inc.’s current 2BB score is 27 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 33 | Weak |
| Quality | 80 | Very Strong |
| Risk | 5 | Very Low |
Company facts
| Headquarters | Nashville, Tennessee, United States |
| Founded | 2009 |
| Employees | 57 |
| 52-week range | $2.33 – $8.51 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.2328 | — | $544,680.00 |
| 2026-08-10 | — | -0.2491 | — | $446,250.00 |
| 2026-05-11 | — | -0.204 | — | $528,360.00 |
| 2026-03-26 | — | -0.242 | — | $295,800.00 |
2BBBullish & Bearish